Quantitative effects on proximal joints of botulinum toxin treatment for gastrocnemius spasticity: a 4-year-old case

Veronica Cimolin1, Manuela Galli, Marcello Crivellini

  • 1Bioengineering Department, Politecnico di Milano, Piaza Leonardo da Vinci 32, 20133 Milano, Italy.

Case Reports in Medicine
|September 5, 2009
PubMed

Insights

Botulinum toxin A injections improved gait in a child with cerebral palsy. While initial hip function temporarily declined, long-term analysis showed significant improvements in ankle, knee, and hip joint movement and power.

Area of Science:

  • Neurology
  • Pediatrics
  • Biomechanical Engineering

Background:

  • Cerebral Palsy (CP) often involves spasticity, impacting motor function.
  • Botulinum Toxin A (BTA) is used for early spasticity management in children with CP.
  • Gait Analysis (GA) is crucial for evaluating motor impairments.

Observation:

  • This study analyzed the gait pattern of a 4-year-old child with diplegic CP and calf contracture.
  • Data were collected before, 5 days after, and 3 months after BTA injections into the gastrocnemius muscle.
  • Kinematic and kinetic data of lower limb joints were meticulously examined.

Findings:

  • Short-term (5 days) BTA treatment improved ankle dorsi-plantarflexion and knee flex-extension but caused compensatory hip flexion.
  • Long-term (3 months) BTA treatment demonstrated generalized improvements in hip and knee range of motion.
  • Significant enhancements in ankle kinematics, kinetics, and propulsive capacity were observed at 3 months post-injection.

Implications:

  • BTA injections can lead to positive long-term gait modifications in children with CP.
  • Dynamic changes in joint compensation patterns warrant further investigation.
  • Optimizing BTA treatment protocols may enhance functional mobility and quality of life in pediatric CP patients.